✦ LIBER ✦

Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749

✍ Scribed by Daniel D. Long; Scott R. Armstrong; David T. Beattie; Seok-Ki Choi; Paul R. Fatheree; Roland A.L. Gendron; Adam A. Goldblum; Patrick P. Humphrey; Daniel G. Marquess; Jeng-Pyng Shaw; Jacqueline A.M. Smith; S. Derek Turner; Ross G. Vickery

Book ID: 116318570
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 548 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.05.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Discovery, Oral Pha

ChemInform Abstract: Discovery, Oral Pharmacokinetics and in vivo Efficacy of a Highly Selective 5-HT 4 Receptor Agonist: Clinical Compound TD-2749.

✍ Long, Daniel D.; et al., et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB

Discovery, oral pharmacokinetics and in

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation

✍ Long, Daniel D.; Armstrong, Scott R.; Beattie, David T.; Choi, Seok-Ki; Fatheree 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 434 KB

S1672 TD-8954 Is a Highly Potent and Sel

S1672 TD-8954 Is a Highly Potent and Selective 5-HT4 Receptor Agonist with Potential Utility in Disorders of Reduced Gastrointestinal Motility

✍ Beattie, David T.; Vickery, Ross G.; Armstrong, Scott R.; Ropenga, Anna; Cuthber 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB